×
For best experience we recommend to activate Javascript in your browser.
LDLR antibody (AA 497-742)
The Rabbit Polyclonal anti-LDLR antibody has been validated for FACS. It is suitable to detect LDLR in samples from Human.
Quick Overview for LDLR antibody (AA 497-742) (ABIN6992499)
Target
See all LDLR Antibodies
LDLR
(Low Density Lipoprotein Receptor (LDLR))
Reactivity
All reactivities for LDLR antibodies
Human
Host
All hosts for LDLR antibodies
Rabbit
Clonality
All clonalities for LDLR antibodies
Polyclonal
Conjugate
All conjugates for LDLR antibodies
This LDLR antibody is un-conjugated
Application
All applications for LDLR antibodies
Flow Cytometry (FACS)
Product Details anti-LDLR Antibody
(hide)
Binding Specificity
All epitopes for LDLR antibodies
AA 497-742
Purpose
Anti-Low Density Lipoprotein Receptor (LDLR) Polyclonal Antibody
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant Low Density Lipoprotein Receptor (LDLR) corresdonding to Thr497~Thr742 with N-terminal His Tag
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
For flow cytometry, the suggested use of this reagent is 1-5 μL per 10^6 cells in 100 μL volume. Optimal working dilutions could be determined by end user.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Expiry Date
12 months
Target Details for LDLR
(hide)
Target
LDLR
(Low Density Lipoprotein Receptor (LDLR))
Alternative Name
Low Density Lipoprotein Receptor
Background
FH, FHC, Familial Hypercholesterolemia
UniProt
P01130
Pathways
Hepatitis C , Lipid Metabolism
Recently viewed
(hide)
Chat with us , powered by LiveChat